Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.05B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$404M |
| 3 |
AstraZeneca
AZN
|
+$342M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$288M |
| 5 |
Willis Towers Watson
WTW
|
+$227M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Icahn Enterprises
IEP
|
+$641M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$538M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$294M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.22% |
| 2 | Financials | 7.52% |
| 3 | Healthcare | 6.46% |
| 4 | Consumer Discretionary | 6.41% |
| 5 | Communication Services | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Webster Financial
WBS
$12.5B
| $6.33M | ﹤0.01% |
118,586
+14,825
| +14% | +$822K |
|
|
XLRN
1702
DELISTED
Acceleron Pharma
XLRN
| $6.32M | ﹤0.01% |
50,331
+4,354
| +9% | +$549K |
|
|
ISBC
1703
DELISTED
Investors Bancorp, Inc.
ISBC
| $6.32M | ﹤0.01% |
442,858
+94,049
| +27% | +$1.39M |
|
|
ETRN
1704
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $6.3M | ﹤0.01% |
740,400
+221,096
| +43% | +$1.87M |
|
1705
First Hawaiian
FHB
$3.42B
| $6.3M | ﹤0.01% |
222,198
+62,123
| +39% | +$1.74M |
|
1706
RenaissanceRe
RNR
$13.9B
| $6.3M | ﹤0.01% |
42,308
-3,332
| -7% | -$530K |
|
1707
Hartford Multifactor Developed Markets ex-US ETF
RODM
$1.61B
| $6.3M | ﹤0.01% |
205,024
+33,212
| +19% | +$1.03M |
|
|
DOC
1708
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $6.29M | ﹤0.01% |
340,323
+123,231
| +57% | +$2.29M |
|
|
SHLX
1709
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $6.28M | ﹤0.01% |
424,840
+118,164
| +39% | +$1.77M |
|
1710
PUT
Barclays
BCS
$91B
| $6.27M | ﹤0.01% |
+650,000
| New | +$6.64M |
|
1711
NOV
NOV
$7.11B
| $6.25M | ﹤0.01% |
407,816
-4,452,807
| -92% | -$69.3M |
|
1712
iShares Russell Mid-Cap ETF
IWR
$56.5B
| $6.25M | ﹤0.01% |
78,837
-7,985
| -9% | -$619K |
|
1713
PUT
Union Pacific
UNP
$175B
| $6.25M | ﹤0.01% |
28,400
+4,700
| +20% | +$1.05M |
|
1714
Lemonade
LMND
$4.77B
| $6.23M | ﹤0.01% |
56,943
-10,446
| -16% | -$948K |
|
1715
ScottsMiracle-Gro
SMG
$4.25B
| $6.21M | ﹤0.01% |
32,384
+8,887
| +38% | +$1.96M |
|
1716
PUT
Best Buy
BBY
$18.9B
| $6.21M | ﹤0.01% |
54,000
+24,000
| +80% | +$2.8M |
|
1717
Myriad Genetics
MYGN
$502M
| $6.21M | ﹤0.01% |
203,031
+61,974
| +44% | +$1.79M |
|
1718
SLM Corp
SLM
$4.74B
| $6.21M | ﹤0.01% |
296,378
-27,670
| -9% | -$545K |
|
|
TWTR
1719
PUT
DELISTED
Twitter, Inc.
TWTR
| $6.19M | ﹤0.01% |
90,000
+40,000
| +80% | +$2.45M |
|
1720
Apple Hospitality REIT
APLE
$3.97B
| $6.19M | ﹤0.01% |
405,665
-91,050
| -18% | -$1.41M |
|
1721
Coinbase
COIN
$44.2B
| $6.19M | ﹤0.01% |
+24,422
| New | +$6.34M |
|
1722
InMode
INMD
$889M
| $6.17M | ﹤0.01% |
130,406
+124,746
| +2,204% | +$5.3M |
|
1723
Ambev
ABEV
$48.4B
| $6.17M | ﹤0.01% |
1,793,911
-1,219,988
| -40% | -$3.97M |
|
1724
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.16B
| $6.16M | ﹤0.01% |
164,262
-1,045
| -0.6% | -$39.1K |
|
1725
FNB Corp
FNB
$6.81B
| $6.16M | ﹤0.01% |
499,509
+7,786
| +2% | +$101K |
|
Similar funds
Citigroup's Q2 2021 Portfolio in Review
As of Q2 2021, Citigroup held 6,654 positions worth $166B, up 7.5% from $155B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup's Q2 2021 filing shows 397 new, 2,681 increased, 2,205 reduced and 444 closed positions. Its largest new stake was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M. The largest sale was Icahn Enterprises, an estimated $641M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q2 2021 buy was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $2.05B increase.
- Citigroup's biggest Q2 2021 reduction was Icahn Enterprises, cutting an estimated $641M.
- Citigroup fully exited RealPage, Inc. in Q2 2021, selling an estimated $226M.
- Citigroup's ten largest holdings make up 20% of its $166B portfolio in Q2 2021.
- Citigroup opened 397 new positions and closed 444 in Q2 2021.
- Citigroup's portfolio value rose 7.5% quarter-over-quarter to $166B.
Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.